Clinical Trial Update: Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating four doses of cenerimod versus placebo in adults with active systemic lupus erythematosus to assess efficacy and safety. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Cenerimod (cenerimod)

Snippet

Sponsor: Viatris Innovation GmbH | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2023-09-22